Boston Scientific Corp. has announced its agreement to acquire medical device manufacturer Penumbra Inc. in a deal valued at over $14 billion. This strategic acquisition aims...
Penumbra, Inc., a leading company in thrombectomy technology, announced it will host an investor event on October 26, 2025, during the 2025 Transcatheter Cardiovascular Therapeutics (TCT)...